Mechanisms of Drug Release in Nanotherapeutic Delivery Systems
The DOI matches its Crossref record; 493 of the 493 references it cites were found in a registry or an index.
Abstract
ADVERTISEMENT RETURN TO ISSUEPREVReviewNEXTMechanisms of Drug Release in Nanotherapeutic Delivery SystemsPamela T. Wong and Seok Ki Choi*View Author Information Michigan Nanotechnology Institute for Medicine and Biological Sciences, Department of Internal Medicine, University of Michigan, Ann Arbor, Michigan 48109, United States*E-mail: [email protected]. Tel.: (734) 647-0052. Fax: (734) 936-2990.Cite this: Chem. Rev. 2015, 115, 9, 3388–3432Publication Date (Web):April 27, 2015Publication History Received22 August 2014Published online27 April 2015Published inissue 13 May 2015https://pubs.acs.org/doi/10.1021/cr5004634https://doi.org/10.1021/cr5004634review-articleACS PublicationsCopyright © 2015 American Chemical SocietyRequest reuse permissionsArticle Views14486Altmetric-Citations396LEARN ABOUT THESE METRICSArticle Views are the COUNTER-compliant sum of full text article downloads since November 2008 (both PDF and HTML) across all institutions and individuals. These metrics are regularly updated to reflect usage leading up to the last few days.Citations are the number of other articles citing this article, calculated by Crossref and updated daily. Find more information about Crossref citation counts.The Altmetric Attention Score is a quantitative measure of the attention that a research article has received online. Clicking on the donut icon will load a page at altmetric.com with additional details about the score and the social media presence for the given article. Find more information on the Altmetric Attention Score and how the score is calculated. Share Add toView InAdd Full Text with ReferenceAdd Description ExportRISCitationCitation and abstractCitation and referencesMore Options Share onFacebookTwitterWechatLinked InRedditEmail Other access optionsGet e-Alertsclose SUBJECTS:Antineoplastic agents,Drug release,Molecules,Organic compounds,Peptides and proteins Get e-Alerts
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Some authors evaluated the encapsulation efficiency of volatile hydrophilic compounds by Gas Chromatography, since, as a result of drug-polymeric micelle interactions, a decrease of the amount of free volatile compounds in bulk water was found [114].”
From Polymeric micelles in drug delivery: An insight of the techniques for their characterization and assessment in biorelevant conditions (2021) · cites this paper as [114]
Citations
Cites
1 retracted
Items 201–400 of 493
Wang, X., Cai, X., Hu, J., Shao, N., Wang, F., Zhang, Q., Xiao, J., & Cheng, Y. (2013) · Journal of the American Chemical Society · doi:10.1021/ja402903h · Cited by 213
Folate-Based Near-Infrared Fluorescent Theranostic Gemcitabine Delivery
Yang, Z., Lee, J. H., Jeon, H. M., Han, J. H., Park, N., He, Y., Lee, H., Hong, K. S., Kang, C., & Kim, J. S. (2013) · Journal of the American Chemical Society · doi:10.1021/ja405372k · Cited by 212
Folate‐targeted nanoparticles show efficacy in the treatment of inflammatory arthritis
Thomas, T. P., Goonewardena, S. N., Majoros, I. J., Kotlyar, A., Cao, Z., Leroueil, P. R., & Baker, J. R. (2011) · Arthritis & Rheumatism · doi:10.1002/art.30459 · Cited by 208
Tumor angiogenic vasculature targeting with PAMAM dendrimer–RGD conjugates
Shukla, R., Thomas, T. P., Peters, J., Kotlyar, A., Myc, A., & Baker, Jr. (2005) · Chemical Communications · doi:10.1039/b507350b · Cited by 205
Effects of Microparticle Size and Fc Density on Macrophage Phagocytosis
Pacheco, P., White, D., & Sulchek, T. (2013) · PLoS ONE · doi:10.1371/journal.pone.0060989 · Cited by 205
Khalili, P., Arakelian, A., Chen, G., Plunkett, M. L., Beck, I., Parry, G. C., Doñate, F., Shaw, D. E., Mazar, A. P., & Rabbani, S. A. (2006) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-06-0100 · Cited by 203
The Transferrin Receptor: A Potential Molecular Imaging Marker for Human Cancer
Högemann-Savellano, D., Bos, E., Blondet, C., Sato, F., Abe, T., Josephson, L., Weissleder, R., Gaudet, J., Sgroi, D., Peters, P. J., et al. (2003) · Neoplasia · doi:10.1016/s1476-5586(03)80034-9 · Cited by 201
Chemotherapy-Induced Cardiotoxicity: Current Practice and Prospects of Prophylaxis
Gharib, M. I., & Burnett, A. K. (2002) · European Journal of Heart Failure · doi:10.1016/s1388-9842(01)00201-x · Cited by 200
Ryser, H. J.-P., & Shen, W.-C. (1978) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.75.8.3867 · Cited by 200
General Base Catalysis of Ester Hydrolysis1
Jencks, W. P., & Carriuolo, J. (1961) · Journal of the American Chemical Society · doi:10.1021/ja01468a044 · Cited by 198
Biomimetic cavity-based metal complexes
Rebilly, J.-N., Colasson, B., Bistri, O., Over, D., & Reinaud, O. (2015) · Chemical Society Reviews · doi:10.1039/c4cs00211c · Cited by 198
Hydrolysis in Drug and Prodrug Metabolism: Chemistry, Biochemistry, and Enzymology
Testa, B., & Mayer, J. M. (2003) · doi:10.1002/9783906390444 · Cited by 196
Zhang, B., & Breslow, R. (1997) · Journal of the American Chemical Society · doi:10.1021/ja963769d · Cited by 193
In Vitro Targeting of Synthesized Antibody-Conjugated Dendrimer Nanoparticles
Thomas, T. P., Patri, A. K., Myc, A., Myaing, M. T., Ye, J. Y., Norris, T. B., & Baker, J. R. (2004) · Biomacromolecules · doi:10.1021/bm049704h · Cited by 193
Endocytosis of GPI-linked membrane folate receptor-alpha.
Rijnboutt, S., Jansen, G., Posthuma, G., Hynes, J. B., Schornagel, J. H., & Strous, G. J. (1996) · The Journal of cell biology · doi:10.1083/jcb.132.1.35 · Cited by 192
Ojima, I. (2008) · Accounts of Chemical Research · doi:10.1021/ar700093f · Cited by 191
UPTAKE, LOCALIZATION, AND NONCARBOXYLASE ROLES OF BIOTIN
Zempleni, J. (2005) · Annual Review of Nutrition · doi:10.1146/annurev.nutr.25.121304.131724 · Cited by 191
Chen, Y., Foss, C. A., Byun, Y., Nimmagadda, S., Pullambhatla, M., Fox, J. J., Castanares, M., Lupold, S. E., Babich, J. W., Mease, R. C., et al. (2008) · Journal of Medicinal Chemistry · doi:10.1021/jm801055h · Cited by 190
Zhu, J., Zheng, L., Wen, S., Tang, Y., Shen, M., Zhang, G., & Shi, X. (2014) · Biomaterials · doi:10.1016/j.biomaterials.2014.05.046 · Cited by 190
Wang, Y., Guo, R., Cao, X., Shen, M., & Shi, X. (2011) · Biomaterials · doi:10.1016/j.biomaterials.2010.12.060 · Cited by 189
Xiao, Y., Hong, H., Matson, V. Z., Javadi, A., Xu, W., Yang, Y., Zhang, Y., Engle, J. W., Nickles, R. J., Cai, W., et al. (2012) · Theranostics · doi:10.7150/thno.4756 · Cited by 189
Chau, Y., Tan, F. E., & Langer, R. (2004) · Bioconjugate Chemistry · doi:10.1021/bc0499174 · Cited by 187
He, L., Huang, Y., Zhu, H., Pang, G., Zheng, W., Wong, Y., & Chen, T. (2014) · Advanced Functional Materials · doi:10.1002/adfm.201303533 · Cited by 185
Polymer therapeutics: Clinical applications and challenges for development
Vicent, M. J., Ringsdorf, H., & Duncan, R. (2009) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2009.08.001 · Cited by 183
Metabolic targeting of hypoxia and HIF1 in solid tumors can enhance cytotoxic chemotherapy
Cairns, R. A., Papandreou, I., Sutphin, P. D., & Denko, N. C. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0611662104 · Cited by 182
Ultrasound and pH Dually Responsive Polymer Vesicles for Anticancer Drug Delivery
Chen, W., & Du, J. (2013) · Scientific Reports · doi:10.1038/srep02162 · Cited by 182
Venkateswaran, V., Haddad, A. Q., Fleshner, N. E., Fan, R., Sugar, L. M., Nam, R., Klotz, L. H., & Pollak, M. (2007) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djm231 · Cited by 182
Geisow, M. J., & Evans, W. H. (1984) · Experimental Cell Research · doi:10.1016/0014-4827(84)90699-2 · Cited by 179
Han, L., Zhao, J., Zhang, X., Cao, W., Hu, X., Zou, G., Duan, X., & Liang, X.-J. (2012) · ACS Nano · doi:10.1021/nn3024688 · Cited by 179
Haluska, P., Carboni, J. M., Loegering, D. A., Lee, F. Y., Wittman, M., Saulnier, M. G., Frennesson, D. B., Kalli, K. R., Conover, C. A., Attar, R. M., et al. (2006) · Cancer Research · doi:10.1158/0008-5472.can-05-1107 · Cited by 179
Wu, G., Barth, R. F., Yang, W., Kawabata, S., Zhang, L., & Green-Church, K. (2006) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-05-0325 · Cited by 177
Ghosh, S. K., Pal, A., Kundu, S., Nath, S., & Pal, T. (2004) · Chemical Physics Letters · doi:10.1016/j.cplett.2004.08.016 · Cited by 176
Dendrimer-based nanodevices for targeted drug delivery applications
Zhu, J., & Shi, X. (2013) · Journal of Materials Chemistry B · doi:10.1039/c3tb20724b · Cited by 175
Wong, A. D., DeWit, M. A., & Gillies, E. R. (2011) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2011.09.012 · Cited by 172
Making polymeric nanoparticles stimuli-responsive with dynamic covalent bonds
Jackson, A. W., & Fulton, D. A. (2013) · Polym. Chem. · doi:10.1039/c2py20727c · Cited by 168
Wang, X., Li, J., Wang, Y., Cho, K. J., Kim, G., Gjyrezi, A., Koenig, L., Giannakakou, P., Shin, H. J. C., Tighiouart, M., et al. (2009) · ACS Nano · doi:10.1021/nn900649v · Cited by 165
Enzyme-mediated hydrolytic activation of prodrugs
Yang, Y.-H., Aloysius, H., Inoyama, D., Chen, Y., & Hu, L.-Q. (2011) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2011.08.001 · Cited by 162
Samorì, C., Ali‐Boucetta, H., Sainz, R., Guo, C., Toma, F. M., Fabbro, C., Ros, T. D., Prato, M., Kostarelos, K., & Bianco, A. (2009) · Chemical Communications · doi:10.1039/b923560d · Cited by 161
Yasuda, Y., Kageyama, T., Akamine, A., Shibata, M., Kominami, E., Uchiyama, Y., & Yamamoto, K. (1999) · Journal of Biochemistry · doi:10.1093/oxfordjournals.jbchem.a022396 · Cited by 161
Targeted delivery of doxorubicin into cancer cells using a folic acid–dendrimer conjugate
Wang, Y., Cao, X., Guo, R., Shen, M., Zhang, M., Zhu, M., & Shi, X. (2011) · Polymer Chemistry · doi:10.1039/c1py00179e · Cited by 160
NMR Insights into Dendrimer-Based Host–Guest Systems
Hu, J., Xu, T., & Cheng, Y. (2012) · Chemical Reviews · doi:10.1021/cr200333h · Cited by 160
Defeo-Jones, D., Garsky, V. M., Wong, B. K., Feng, D.-M., Bolyar, T., Haskell, K., KIEFER, D. M., Leander, K. R., McAvoy, E., Lumma, P. K., et al. (2000) · Nature Medicine · doi:10.1038/81351 · Cited by 159
Savariar, E. N., Felsen, C. N., Nashi, N., Jiang, T., Ellies, L. G., Steinbach, P., Tsien, R. Y., & Nguyen, Q. T. (2013) · Cancer Research · doi:10.1158/0008-5472.can-12-2969 · Cited by 159
Hu, X., Tian, J., Liu, T., Zhang, G., & Liu, S. (2013) · Macromolecules · doi:10.1021/ma400691j · Cited by 159
Ultrasonically activated chemotherapeutic drug delivery in a rat model.
Nelson, J. L., Roeder, B. L., Carmen, J. C., Roloff, F., & Pitt, W. G. (2002) · PubMed · Cited by 158
Zhou, L., Cheng, R., Tao, H., Ma, S., Guo, W., Meng, F., Liu, H., Liu, Z., & Zhong, Z. (2011) · Biomacromolecules · doi:10.1021/bm101340u · Cited by 158
Liu, R., Li, D., He, B., Xu, X., Sheng, M., Lai, Y., Wang, G., & Gu, Z. (2011) · Journal of Controlled Release · doi:10.1016/j.jconrel.2011.02.031 · Cited by 157
Perturbation of physiological systems by nanoparticles
Zhang, Y., Bai, Y., Jia, J., Gao, N., Li, Y., Zhang, R., Jiang, G., & Yan, B. (2014) · Chemical Society Reviews · doi:10.1039/c3cs60338e · Cited by 157
van der Heijden, J. W., Oerlemans, R., Dijkmans, B. A. C., Qi, H., van der Laken, C. J., Lems, W. F., Jackman, A. L., Kraan, M. C., Tak, P. P., Ratnam, M., et al. (2008) · Arthritis & Rheumatism · doi:10.1002/art.24219 · Cited by 157
Xu, X., Flores, J. D., & McCormick, C. L. (2011) · Macromolecules · doi:10.1021/ma102804h · Cited by 155
Kommareddy, S., & Amiji, M. M. (2007) · Nanomedicine Nanotechnology Biology and Medicine · doi:10.1016/j.nano.2006.11.005 · Cited by 154
Hlavacek, W. S., Posner, R. G., & Perelson, A. S. (1999) · Biophysical Journal · doi:10.1016/s0006-3495(99)77456-4 · Cited by 154
Poon, L. C.-H., Zandberg, W. F., Hsiao, D., Erno, Z., Sen, D., Gates, B. D., & Branda, N. R. (2010) · ACS Nano · doi:10.1021/nn1016346 · Cited by 154
Polymer–drug conjugates as nano-sized medicines
Canal, F., Sanchis, J., & Vicent, M. J. (2011) · Current Opinion in Biotechnology · doi:10.1016/j.copbio.2011.06.003 · Cited by 153
Magnetic hydrogel nanocomposites as remote controlled microfluidic valves
Satarkar, N. S., Zhang, W., Eitel, R. E., & Hilt, J. Z. (2009) · Lab on a Chip · doi:10.1039/b822694f · Cited by 152
Targeting the multiple myeloma hypoxic niche with TH-302, a hypoxia-activated prodrug
Hu, J., Handisides, D. R., Van Valckenborgh, E., De Raeve, H., Menu, E., Vande Broek, I., Liu, Q., Sun, J. D., Van Camp, B., Hart, C. P., et al. (2010) · Blood · doi:10.1182/blood-2010-02-269126 · Cited by 152
Fu, F., Wu, Y., Zhu, J., Wen, S., Shen, M., & Shi, X. (2014) · ACS Applied Materials & Interfaces · doi:10.1021/am504849x · Cited by 151
Fluorescein conjugates as indicators of subcellular pH
Geisow, M. J. (1984) · Experimental Cell Research · doi:10.1016/0014-4827(84)90698-0 · Cited by 149
A polymeric drug for treatment of inflammatory bowel disease
Brown, J. P., McGarraugh, G. V., Parkinson, T. M., Wingard, R. E., & Onderdonk, A. B. (1983) · Journal of Medicinal Chemistry · doi:10.1021/jm00363a015 · Cited by 149
Tumor accumulation, degradation and pharmacokinetics of elastin-like polypeptides in nude mice
Liu, W., Dreher, M. R., Furgeson, D. Y., Peixoto, K. V., Yuan, H., Zalutsky, M. R., & Chilkoti, A. (2006) · Journal of Controlled Release · doi:10.1016/j.jconrel.2006.06.026 · Cited by 149
Hybridization and Enzymatic Extension of Au Nanoparticle-Bound Oligonucleotides
Peña, S. R. N., Raina, S., Goodrich, G. P., Fedoroff, N. V., & Keating, C. D. (2002) · Journal of the American Chemical Society · doi:10.1021/ja0177915 · Cited by 149
Choi, S. K., Myc, A., Silpe, J. E., Sumit, M., Wong, P. T., McCarthy, K. A., Desai, A. M., Thomas, T. P., Kotlyar, A., Holl, M. M. B., et al. (2012) · ACS Nano · doi:10.1021/nn3038995 · Cited by 148
Self-citationSubstrate Specificity of Human Collagenase 3 Assessed Using a Phage-displayed Peptide Library
Deng, S.-J., Bickett, D. M., Mitchell, J. L., Lambert, M. H., Blackburn, K., Carter, H. L., Neugebauer, J. M., Pahel, G. L., Weiner, M. P., & Moss, M. L. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m004538200 · Cited by 147
Polyvalent Dendrimer-Methotrexate as a Folate Receptor-Targeted Cancer Therapeutic
Thomas, T. P., Huang, B., Choi, S. K., Silpe, J. E., Kotlyar, A., Desai, A. M., Zong, H., Gam, J., Joice, M., & Baker, J. R. (2012) · Molecular Pharmaceutics · doi:10.1021/mp3002232 · Cited by 145
Self-citationChoi, S. K., Thomas, T. P., Li, M.-H., Kotlyar, A., Desai, A. M., & Baker, J. R. (2010) · Chemical Communications · doi:10.1039/b927215c · Cited by 145
Self-citationKaminskas, L. M., Kelly, B. D., McLeod, V. M., Boyd, B. J., Krippner, G. Y., Williams, E. D., & Porter, C. J. H. (2009) · Molecular Pharmaceutics · doi:10.1021/mp900049a · Cited by 140
Zhang, L., Li, Y., & Yu, J. C. (2013) · Journal of Materials Chemistry B · doi:10.1039/c3tb21196g · Cited by 140
Trimethyl lock: a trigger for molecular release in chemistry, biology, and pharmacology
Levine, M. N., & Raines, R. T. (2012) · Chemical Science · doi:10.1039/c2sc20536j · Cited by 139
Lee, S., Zhu, X.-M., Wáng, Y. X. J., Xuan, S., You, Q., Chan, W. H., Wong, C.-H., Wang, F., Yu, J. C., Cheng, C. H. K., et al. (2013) · ACS Applied Materials & Interfaces · doi:10.1021/am4004705 · Cited by 138
Wu, C., Wang, Z., Zhi, Z., Jiang, T., Zhang, J., & Wang, S. (2010) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2010.09.040 · Cited by 137
Kaminskas, L. M., Kelly, B. D., McLeod, V. M., Sberna, G., Owen, D. J., Boyd, B. J., & Porter, C. J. H. (2011) · Journal of Controlled Release · doi:10.1016/j.jconrel.2011.02.005 · Cited by 137
Vitamin E succinate and cancer treatment: a vitamin E prototype for selective antitumour activity
Neužil, J. (2003) · British Journal of Cancer · doi:10.1038/sj.bjc.6601360 · Cited by 137
Henderson, E. A., Bavetsias, V., Theti, D. S., Wilson, S. C., Clauss, R., & Jackman, A. L. (2006) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2006.03.001 · Cited by 137
E-selectin as a target for drug delivery and molecular imaging
Jubeli, E., Moine, L., Vergnaud, J., & BARRATT, G. M. (2011) · Journal of Controlled Release · doi:10.1016/j.jconrel.2011.09.084 · Cited by 137
Fant, K., Esbjörner, E. K., Jenkins, A., Grossel, M. C., Lincoln, P., & Nordén, B. (2010) · Molecular Pharmaceutics · doi:10.1021/mp1001312 · Cited by 135
Habeeb, A. F. S. A., & Atassi, M. Z. (1970) · Biochemistry · doi:10.1021/bi00827a016 · Cited by 135
Determination of endogenous thiols and thiol drugs in urine by HPLC with ultraviolet detection
Kuśmierek, K., Chwatko, G., Głowacki, R., & Bald, E. (2009) · Journal of Chromatography B · doi:10.1016/j.jchromb.2009.03.038 · Cited by 134
Permission to Enter Cell by Shape: Nanodisk vs Nanosphere
Zhang, Y., Tekobo, S., Tu, Y., Zhou, Q., Jin, X., Dergunov, S. A., Pinkhassik, E., & Yan, B. (2012) · ACS Applied Materials & Interfaces · doi:10.1021/am300840p · Cited by 132
Li, M., Tang, Z., Sun, H. Y., Ding, J., Song, W., & Chen, X. (2012) · Polymer Chemistry · doi:10.1039/c2py20871g · Cited by 131
Kurapati, R., & Raichur, A. M. (2012) · Chemical Communications · doi:10.1039/c2cc38417e · Cited by 131
Nanoparticle-mediated targeting of MAPK signaling predisposes tumor to chemotherapy
Basu, S., Harfouche, R., Soni, S., Chimote, G., Mashelkar, R. A., & Sengupta, S. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0902857106 · Cited by 129
Acidic Extracellular pH Promotes Activation of Integrin αvβ3
Paradise, R. K., Lauffenburger, D. A., & Vliet, K. J. V. (2011) · PLoS ONE · doi:10.1371/journal.pone.0015746 · Cited by 126
Wosikowski, K., Biedermann, E., Rattel, B., Breiter, N., Jank, P., Löser, R., Jansen, G., & Peters, G. J. (2003) · PubMed · Cited by 126
Application of Ultrasound to Selectively Localize Nanodroplets for Targeted Imaging and Therapy
Dayton, P. A., Zhao, S., Bloch, S. H., Schumann, P., Penrose, K., Matsunaga, T. O., Zutshi, R., Doinikov, A. A., & Ferrara, K. W. (2006) · Molecular Imaging · doi:10.2310/7290.2006.00019 · Cited by 123
Microtubule Structure at Improved Resolution
Grob, P., Kasparian, J., & Wade, R. H. (2001) · Biochemistry · doi:10.1021/bi010343p · Cited by 123
Antitumor efficacy of a novel polymer-peptide-drug conjugate in human tumor xenograft models
Chau, Y., Padera, R. F., Dang, N. M., & Langer, R. (2006) · International Journal of Cancer · doi:10.1002/ijc.21495 · Cited by 123
Carboxylesterases expressed in human colon tumor tissue and their role in CPT-11 hydrolysis.
Sanghani, S. P., Quinney, S. K., Fredenburg, T. B., Sun, Z., Davis, W. I., Murry, D. J., Cummings, O. W., Seitz, D. E., & BOSRON, W. F. (2003) · PubMed · Cited by 122
Louguet, S., Rousseau, B., Epherre, R., Guidolin, N., Goglio, G., Mornet, S., Duguet, É., Lecommandoux, S., & Schatz, C. (2012) · Polymer Chemistry · doi:10.1039/c2py20089a · Cited by 122
A phase I and pharmacokinetic study of MAG-CPT, a water-soluble polymer conjugate of camptothecin
Schoemaker, N. E., van Kesteren, C., Rosing, H., Jansen, S., Swart, M., Lieverst, J. A., Fraier, D., Breda, M., Pellizzoni, C., Spinelli, R., et al. (2002) · British Journal of Cancer · doi:10.1038/sj.bjc.6600516 · Cited by 122
Current Dendrimer Applications in Cancer Diagnosis and Therapy
Majoros, I., Williams, C., & Baker, J. R. (2008) · Current Topics in Medicinal Chemistry · doi:10.2174/156802608785849049 · Cited by 122
Sood, A., Salih, S., Roh, D., Lacharme-Lora, L., Parry, M., Hardiman, B., Keehan, R., Grummer, R., Winterhager, E., Gokhale, P. J., et al. (2011) · Nature Nanotechnology · doi:10.1038/nnano.2011.188 · Cited by 122
Redox-sensitive shell cross-linked PEG–polypeptide hybrid micelles for controlled drug release
Wang, K., Luo, G., Liu, Y., Li, C., Cheng, S., Zhuo, R., & Zhang, X. (2012) · Polymer Chemistry · doi:10.1039/c2py00600f · Cited by 121
Polymer-coated mesoporous silica nanoparticles for the controlled release of macromolecules
Bhattacharyya, S., Wang, H., & Ducheyne, P. (2012) · Acta Biomaterialia · doi:10.1016/j.actbio.2012.06.003 · Cited by 120
Tedeschi, G., Chen, S., & Massey, V. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.3.1198 · Cited by 119
M.Green, R., Graham, M., O’Donovan, M. R., Chipman, J. K., & Hodges, N. J. (2006) · Mutagenesis · doi:10.1093/mutage/gel043 · Cited by 119
Tumor-Specific Novel Taxoid−Monoclonal Antibody Conjugates
Ojima, I., Geng, X., Wu, X., Qu, C., Borella, C. P., Xie, H., Wilhelm, S. D., Leece, B. A., Bartle, L. M., Goldmacher, V. S., et al. (2002) · Journal of Medicinal Chemistry · doi:10.1021/jm025540g · Cited by 116
Tumor Specific Novel Taxoid-Monoclonal Antibody Conjugates
Wu, X., & Ojima, I. (2004) · Current Medicinal Chemistry · doi:10.2174/0929867043455963 · Cited by 115
Yu, S., Ding, J., He, C., Cao, Y. Z., Xu, W., & Chen, X. (2013) · Advanced Healthcare Materials · doi:10.1002/adhm.201300308 · Cited by 114
Dendrimer-Based Targeted Delivery of an Apoptotic Sensor in Cancer Cells
Myc, A., Majoros, I., Thomas, T. P., & Baker, J. R. (2006) · Biomacromolecules · doi:10.1021/bm060815l · Cited by 114
Walker, J. W., McCray, J. A., & Hess, G. P. (1986) · Biochemistry · doi:10.1021/bi00355a052 · Cited by 114
On the nature of low- and high-affinity EGF receptors on living cells
Özcan, F., Klein, P., Lemmon, M. A., Lax, I., & Schlessinger, J. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0601469103 · Cited by 112
Paleos, C. M., Tsiourvas, D., Sideratou, Z., & Tziveleka, L. (2004) · Biomacromolecules · doi:10.1021/bm030068h · Cited by 111
Kim, T., Rothmund, T., Kissel, T., & Kim, S. W. (2011) · Journal of Controlled Release · doi:10.1016/j.jconrel.2011.02.013 · Cited by 111
CRLX101 (formerly IT-101) – A Novel Nanopharmaceutical of Camptothecin in Clinical Development
Young, C., Schluep, T., Hwang, J., & Eliasof, S. (2011) · Current Bioactive Compounds · doi:10.2174/157340711795163866 · Cited by 110
Zhang, W., Nowlan, D. T., Thomson, L. M., Lackowski, W. M., & Simanek, E. E. (2001) · Journal of the American Chemical Society · doi:10.1021/ja0041369 · Cited by 109
de Groot, F. M. H., van Berkom, L. W. A., & Scheeren, H. W. (2000) · Journal of Medicinal Chemistry · doi:10.1021/jm0009078 · Cited by 109
Folate-decorated maleilated pullulan–doxorubicin conjugate for active tumor-targeted drug delivery
Zhang, H., Li, F., Yi, J., Gu, C., Fan, L., Qiao, Y., Tao, Y., Cheng, C., & Wu, H. (2011) · European Journal of Pharmaceutical Sciences · doi:10.1016/j.ejps.2011.02.006 · Cited by 109
Berchane, N. S., Carson, K. H., Rice-Ficht, A. C., & Andrews, M. J. (2007) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2006.12.037 · Cited by 108
Noncovalent Assembly of a Fifteen-Component Hydrogen-Bonded Nanostructure
Jolliffe, K. A., Timmerman, P., & Reinhoudt, D. N. (1999) · Angewandte Chemie International Edition · doi:10.1002/(sici)1521-3773(19990401)38:7<945::aid-anie945>3.0.co;2-s · Cited by 108
Greenwald, R. B., Choe, Y. H., Conover, C. D., Shum, K. L., Wu, D., & Royzen, M. (2000) · Journal of Medicinal Chemistry · doi:10.1021/jm990498j · Cited by 107
Simnick, A. J., Valencia, C. A., Liu, R., & Chilkoti, A. (2010) · ACS Nano · doi:10.1021/nn901732h · Cited by 106
Bifunctional PAMAM Dendrimer Conjugates of Folic Acid and Methotrexate with Defined Ratio
Zong, H., Thomas, T. P., Lee, K.-H., Desai, A. M., Li, M.-H., Kotlyar, A., Zhang, Y., Leroueil, P. R., Gam, J. J., Holl, M. M. B., et al. (2012) · Biomacromolecules · doi:10.1021/bm201639c · Cited by 102
Whitney, M., Savariar, E. N., Friedman, B., Levin, R. A., Crisp, J. L., Glasgow, H. L., Lefkowitz, R., Adams, S. R., Steinbach, P., Nashi, N., et al. (2013) · Angewandte Chemie International Edition · doi:10.1002/anie.201205721 · Cited by 102
Poly(amidoamine) Dendrimers on Lipid Bilayers II: Effects of Bilayer Phase and Dendrimer Termination
Kelly, C. V., Leroueil, P. R., Orr, B. G., Holl, M. M. B., & Andricioaei, I. (2008) · The Journal of Physical Chemistry B · doi:10.1021/jp8013783 · Cited by 101
Yellepeddi, V., Kumar, A., & Palakurthi, S. (2009) · PubMed · Cited by 100
A photochemical approach for controlled drug release in targeted drug delivery
Choi, S. K., Verma, M., Silpe, J. E., Moody, R. E., Tang, K., Hanson, J. J., & Baker, J. R. (2011) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2011.12.020 · Cited by 100
Self-citationYurkovetskiy, A., & Fram, R. J. (2009) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2009.01.007 · Cited by 100
Tougou, K., Nakamura, A., Watanabe, S., Okuyama, Y., & MORINO, A. (1998) · PubMed · Cited by 99
Advances in Biochemical Pharmacology
Bidlack, J. M. (1994) · Archives of Neurology · doi:10.1001/archneur.1994.00540130017006 · Cited by 98
Lim, J., Chouai, A., Lo, S., Liu, W., Sun, X., & Simanek, E. E. (2009) · Bioconjugate Chemistry · doi:10.1021/bc900324z · Cited by 97
FcRL5 as a Target of Antibody–Drug Conjugates for the Treatment of Multiple Myeloma
Elkins, K., Zheng, B., Go, M., Slaga, D., Du, C., Scales, S. J., Yu, S.-F., McBride, J., de Tute, R., Rawstron, A., et al. (2012) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-12-0087 · Cited by 97
A Caged Retinoic Acid for One‐ and Two‐Photon Excitation in Zebrafish Embryos
Neveu, P. A., Aujard, I., Benbrahim, C., Saux, T. L., Allemand, J., Vriz, S., Bensimon, D., & Jullien, L. (2008) · Angewandte Chemie International Edition · doi:10.1002/anie.200800037 · Cited by 94
Chau, Y., Dang, N. M., Tan, F. E., & Langer, R. (2006) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.20548 · Cited by 94
Chen, X., Cheng, X., Soeriyadi, A. H., Sagnella, S. M., Lu, X., Scott, J. A., Lowe, S. B., Kavallaris, M., & Gooding, J. J. (2013) · Biomaterials Science · doi:10.1039/c3bm60148j · Cited by 93
Metallo, S. J., Kane, R. S., Holmlin, R. E., & Whitesides, G. M. (2003) · Journal of the American Chemical Society · doi:10.1021/ja030045a · Cited by 92
Kojima, C., Suehiro, T., Watanabe, K., Ogawa, M., Fukuhara, A., Nishisaka, E., Harada, A., Kono, K., Inui, T., & Magata, Y. (2012) · Acta Biomaterialia · doi:10.1016/j.actbio.2012.11.013 · Cited by 91
Polylactide‐cyclosporin A nanoparticles for targeted immunosuppression
Azzi, J. R., Tang, L., Moore, R. F., Tong, R., Haddad, N. E., Akiyoshi, T., Mfarrej, B. G., Yang, S., Jurewicz, M. M., Ichimura, T., et al. (2010) · The FASEB Journal · doi:10.1096/fj.10-154690 · Cited by 89
Reductively activated disulfide prodrugs of paclitaxel
Vrudhula, V. M., MacMaster, J. F., Li, Z., Kerr, D. E., & Senter, P. D. (2002) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/s0960-894x(02)00784-9 · Cited by 89
Liu, K., Xu, L., Szalkowski, D., Li, Z., Ding, V. D. H., Kwei, G. Y., Huskey, S.-E. W., Moller, D. E., Heck, J. V., Zhang, B. B., et al. (2000) · Journal of Medicinal Chemistry · doi:10.1021/jm000285q · Cited by 89
Shi, X., Lee, I., Chen, X., Shen, M., Xiao, S., Zhu, M., Baker, J. R., & Wang, S. H. (2010) · Soft Matter · doi:10.1039/b925274f · Cited by 86
de Groot, F. M. H., Broxterman, H. J., Adams, H. P. H. M., van Vliet, A., TESSER, G. I., Elderkamp, Y. W., Schraa, A. J., Kok, R. J., Molema, G., Pinedo, H. M., et al. (2002) · PubMed · Cited by 86
Taurine binding to the purified insulin receptor
Maturo, J. M., & Kulakowski, E. C. (1988) · Biochemical Pharmacology · doi:10.1016/0006-2952(88)90411-x · Cited by 85
Dendrimer-based multivalent methotrexates as dual acting nanoconjugates for cancer cell targeting
Li, M.-H., Choi, S. K., Thomas, T. P., Desai, A. M., Lee, K.-H., Kotlyar, A., Holl, M. M. B., & Baker, J. R. (2011) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2011.11.027 · Cited by 85
Self-citationAzo Chemistry and Its Potential for Colonic Delivery
Jain, A., Gupta, Y., & Jain, S. (2006) · Critical Reviews in Therapeutic Drug Carrier Systems · doi:10.1615/critrevtherdrugcarriersyst.v23.i5.10 · Cited by 85
Kopečková, P., & Kopec̆ek, J. (1990) · Die Makromolekulare Chemie · doi:10.1002/macp.1990.021910906 · Cited by 83
Methotrexate delivery via folate targeted dendrimer‐based nanotherapeutic platform
Majoros, I., WILLIAMS, C. R., Becker, A., & Baker, J. R. (2009) · Wiley Interdisciplinary Reviews Nanomedicine and Nanobiotechnology · doi:10.1002/wnan.37 · Cited by 83
HER2 specific delivery of methotrexate by dendrimer conjugated anti-HER2 mAb
Shukla, R., Thomas, T. P., Desai, A. M., Kotlyar, A., Park, S. J., & Baker Jr, J. R. (2008) · Nanotechnology · doi:10.1088/0957-4484/19/29/295102 · Cited by 82
Bao, C., Fan, G., Lin, Q., Li, B., Cheng, S., Huang, Q., & Zhu, L. (2011) · Organic Letters · doi:10.1021/ol203188h · Cited by 82
Incorvaia, L., Badalamenti, G., Rini, G., Arcara, C., Fricano, S., Sferrazza, C., Trapani, D. D., Gebbia, N., & Leto, G. (2007) · PubMed · Cited by 82
Design of riboflavin-presenting PAMAM dendrimers as a new nanoplatform for cancer-targeted delivery
Thomas, T. P., Choi, S. K., Li, M.-H., Kotlyar, A., & Baker, J. R. (2010) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2010.07.005 · Cited by 81
Self-citationThe reversal of methotrexate toxicity by thymidine with maintenance of antitumour effects
Tattersall, M. H. N., Brown, B. L., & Frei, E. (1975) · Nature · doi:10.1038/253198a0 · Cited by 81
Link, K. H., Shi, Y., & Koh, J. T. (2005) · Journal of the American Chemical Society · doi:10.1021/ja0531226 · Cited by 81
Biorecognizable HPMA copolymer–drug conjugates for colon-specific delivery of 9-aminocamptothecin
Sakuma, S., Lu, Z., Kopečková, P., & Kopec̆ek, J. (2001) · Journal of Controlled Release · doi:10.1016/s0168-3659(01)00405-9 · Cited by 80
Olson, E. S., Whitney, M. A., Friedman, B., Aguilera, T. A., Crisp, J. L., Baik, F. M., Jiang, T., Baird, S. M., Tsimikas, S., Tsien, R. Y., et al. (2012) · Integrative Biology · doi:10.1039/c2ib00161f · Cited by 80
Stereopopulation control. II. Rate enhancement of intramolecular nucleophilic displacement
Borchardt, R. T., & Cohen, L. A. (1972) · Journal of the American Chemical Society · doi:10.1021/ja00781a030 · Cited by 80
Houba, P. H. J., Boven, E., van der Meulen‐Muileman, I. H., Leenders, R. G. G., Scheeren, J. W., Pinedo, H. M., & Haisma, H. J. (2001) · British Journal of Cancer · doi:10.1054/bjoc.2000.1640 · Cited by 80
Chen, H., Song, I., Hossain, A., Choi, M., YAMANE, Y., Zheng, L., Lu, J., Wu, L. Y. H., Siddik, Z. H., Klomp, L. W. J., et al. (2008) · Molecular Pharmacology · doi:10.1124/mol.108.047969 · Cited by 80
EO9 (Apaziquone): from the clinic to the laboratory and back again
Phillips, R. M., Hendriks, H. R., Peters, G. J., & on behalf of the EORTC‐Pharmacology and Molecular Mechanism Group (2013) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2012.01996.x · Cited by 79
Dendrimer−Epidermal Growth Factor Conjugate Displays Superagonist Activity
Thomas, T. P., Shukla, R., Kotlyar, A., Liang, B., Ye, J. Y., Norris, T. B., & Baker, J. R. (2008) · Biomacromolecules · doi:10.1021/bm701185p · Cited by 79
Redox‐ and Temperature‐Controlled Drug Release from Hollow Mesoporous Silica Nanoparticles
Jiao, Y., Sun, Y., Chang, B., Lu, D., & Yang, W. (2013) · Chemistry - A European Journal · doi:10.1002/chem.201301060 · Cited by 79
Bolling, C., Graefe, T., Lübbing, C., Jankevičius, F., Uktveris, S., Česas, A., Meyer‐Moldenhauer, W., Starkmann, H., Weigel, M. T., Burk, K., et al. (2006) · Investigational New Drugs · doi:10.1007/s10637-006-8221-6 · Cited by 79
López‐Noriega, A., Hastings, C. L., Ozbakir, B., O’Donnell, K., O’Brien, F. J., Storm, G., Hennink, W. E., Duffy, G. P., & Ruiz‐Hernández, E. (2014) · Advanced Healthcare Materials · doi:10.1002/adhm.201300649 · Cited by 78
pH-Triggered Release of Platinum Drugs Conjugated to Micelles via an Acid-Cleavable Linker
Binauld, S., Scarano, W., & Stenzel, M. H. (2012) · Macromolecules · doi:10.1021/ma3012812 · Cited by 78
Noguchi, M., Skwarczyński, M., Prakash, H., Hirota, S., Kimura, T., Hayashi, Y., & Kiso, Y. (2008) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2008.04.022 · Cited by 78
Folate receptor specific anti-tumor activity of folate–mitomycin conjugates
Reddy, J. A., Westrick, E. M., Vlahov, I. R., Howard, S. J., Santhapuram, H. K. R., & Leamon, C. P. (2005) · Cancer Chemotherapy and Pharmacology · doi:10.1007/s00280-005-0151-z · Cited by 78
Esterase-like activity of human serum albumin toward prodrug esters of nicotinic acid.
Salvi, A., Carrupt, P., Mayer, J. M., & Testa, B. (1997) · PubMed · Cited by 78
Rodrigues, M. L., Presta, L. G., Kotts, C. E., Wirth, C., Mordenti, J. J., Osaka, G., Wong, W. L., Nuijens, A., Blackburn, B. K., & Carter, P. M. (1995) · PubMed · Cited by 78
Light-Mediated Inhibition of Protein Synthesis
Goard, M. J., Aakalu, G., Fedoryak, O. D., Quiñonez, C., Julien, J. S., Poteet, S. J., Schuman, E. M., & Dore, T. M. (2005) · Chemistry & Biology · doi:10.1016/j.chembiol.2005.04.018 · Cited by 77
IHOVA, B. (2003) · Journal of Controlled Release · doi:10.1016/s0168-3659(03)00235-9 · Cited by 77
Dual responsive supramolecular nanogels for intracellular drug delivery
Chen, X., Chen, L., Yao, X., Zhang, Z., He, C., Zhang, J., & Chen, X. (2014) · Chemical Communications · doi:10.1039/c4cc00016a · Cited by 76
Determinants for the drug release from T-0128, camptothecin analogue-carboxymethyl dextran conjugate
Harada, M., Sakakibara, H., Yano, T., Suzuki, T., & Okuno, S. (2000) · Journal of Controlled Release · doi:10.1016/s0168-3659(00)00321-7 · Cited by 76
Wong, S., Shim, M. S., & Kwon, Y. J. (2013) · Journal of Materials Chemistry B · doi:10.1039/c3tb21344g · Cited by 76
Tumour-selective drug delivery via folate receptor-targeted liposomes
Pan, X., & Lee, R. J. (2004) · Expert Opinion on Drug Delivery · doi:10.1517/17425247.1.1.7 · Cited by 76
Two-photon micropatterning of amines within an agarose hydrogel
Wylie, R. G., & Shoichet, M. S. (2008) · Journal of Materials Chemistry · doi:10.1039/b718431j · Cited by 75
Development of first photoresponsive prodrug of paclitaxel
Skwarczyński, M., Noguchi, M., Hirota, S., Sohma, Y., Kimura, T., Hayashi, Y., & Kiso, Y. (2006) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2006.06.030 · Cited by 75
Novel hyaluronic acid–methotrexate conjugates for osteoarthritis treatment
Homma, A., Sato, H., Okamachi, A., Emura, T., Ishizawa, T., Kato, T., Matsuura, T., Sato, S., Tamura, T., Higuchi, Y., et al. (2009) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2009.04.063 · Cited by 75
Boghaert, E. R., Sridharan, L., Armellino, D. C., Khandke, K. M., DiJoseph, J. F., Kunz, A., Dougher, M. M., Jiang, F., Kalyandrug, L. B., Hamann, P. R., et al. (2004) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-04-0037 · Cited by 75
Sinha, D. K., Neveu, P. A., Gagey‐Eilstein, N., Aujard, I., Saux, T. L., Rampon, C., Gauron, C., Kawakami, K., Leucht, C., Bally‐Cuif, L., et al. (2010) · Zebrafish · doi:10.1089/zeb.2009.0632 · Cited by 73
Silpe, J. E., Sumit, M., Thomas, T. P., Huang, B., Kotlyar, A., van Dongen, M. A., Holl, M. M. B., Orr, B. G., & Choi, S. K. (2013) · ACS Chemical Biology · doi:10.1021/cb400258d · Cited by 72
Self-citationJiang, Y., Tang, G., Zhang, L.-H., Kong, S.-Y., Zhu, S., & Pei, Y. (2010) · Journal of drug targeting · doi:10.3109/10611860903494203 · Cited by 72
Peptide‐mediated cancer targeting of nanoconjugates
Raha, S., Paunesku, T., & Woloschak, G. E. (2010) · Wiley Interdisciplinary Reviews Nanomedicine and Nanobiotechnology · doi:10.1002/wnan.121 · Cited by 70
Hu, J., Cheng, Y., Wu, Q., Zhao, L., & Xu, T. (2009) · The Journal of Physical Chemistry B · doi:10.1021/jp9047055 · Cited by 69
Synthesis and β-lactamase-mediated activation of a cephalosporin-taxol prodrug
Rodrigues, M. L., Carter, P. M., Wirth, C., Mullins, S., Lee, A. M., & Blackburn, B. K. (1995) · Chemistry & Biology · doi:10.1016/1074-5521(95)90272-4 · Cited by 69
Temperature‐Sensitive Magnetic Drug Carriers for Concurrent Gemcitabine Chemohyperthermia
Kim, D., Guo, Y., Zhang, Z., Procissi, D., Nicolai, J., Omary, R. A., & Larson, A. C. (2013) · Advanced Healthcare Materials · doi:10.1002/adhm.201300209 · Cited by 69
Gu, Y., Patterson, A. V., Atwell, G. J., Chernikova, S. B., Brown, J. M., Thompson, L. H., & Wilson, W. R. (2009) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-08-1209 · Cited by 69
Doxorubicin-formaldehyde conjugates targeting alphavbeta3 integrin.
Burkhart, D. J., Kalet, B. T., Coleman, M. P., Post, G. C., & Koch, T. H. (2004) · PubMed · Cited by 69
Zhang, Y., Thomas, T. P., Lee, K.-H., Li, M., Zong, H., Desai, A. M., Kotlyar, A., Huang, B., Holl, M. M. B., & Baker, J. R. (2011) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2011.03.019 · Cited by 67
Zimmerman, S. C., Quinn, J. R., Burakowska, E., & Haag, R. (2007) · Angewandte Chemie International Edition · doi:10.1002/anie.200702580 · Cited by 67
Carboxyl-Terminated PAMAM-SN38 Conjugates: Synthesis, Characterization, and in Vitro Evaluation
Vijayalakshmi, N., Ray, A., Malugin, A., & Ghandehari, H. (2010) · Bioconjugate Chemistry · doi:10.1021/bc100094z · Cited by 66
Liver enzyme changes in the developing rat.
Butler, P. J., Harris, J. I., Hartley, B. S., & LEBERMAN, R. (1967) · PubMed Central · Cited by 65
Bioadhesive N-(2-hydroxypropyl) methacrylamide copolymers for colon-specific drug delivery
Kopečková, P., Rathi, R., Takada, S., Říhová, B., Berenson, M. M., & Kopec̆ek, J. (1994) · Journal of Controlled Release · doi:10.1016/0168-3659(94)90168-6 · Cited by 65
Strategies for covalently reticulated polymer multilayers
Rydzek, G., Schaaf, P., Voegel, J., Jierry, L., & Boulmedais, F. (2012) · Soft Matter · doi:10.1039/c2sm25719j · Cited by 65
Chen, K., Wang, K., Kirichian, A. M., Aowad, A. F. A., Iyer, L. K., Adelstein, S. J., & Kassis, A. I. (2006) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-06-0465 · Cited by 65
E-selectin up-regulation allows for targeted drug delivery in prostate cancer.
Bhaskar, V., Law, D. A., Ibsen, E. M., Breinberg, D., Cass, K. M., DuBridge, R. B., Evangelista, F., Henshall, S. M., Hevezi, P. A., Miller, J. C., et al. (2003) · PubMed · Cited by 65
Synthesis of novel paclitaxel prodrugs designed for bioreductive activation in hypoxic tumour tissue
Damen, E. W. P., Nevalainen, T., van den Bergh, T. J. M., de Groot, F. M. H., & Scheeren, H. W. (2002) · Bioorganic & Medicinal Chemistry · doi:10.1016/s0968-0896(01)00235-8 · Cited by 64
Gianasi, E., Buckley, R. G., Latigo, J., Wasil, M., & Duncan, R. (2002) · Journal of Drug Targeting · doi:10.1080/1061186021000072456 · Cited by 64
Kaminskas, L. M., Kelly, B. D., McLeod, V. M., Sberna, G., Boyd, B. J., Owen, D. J., & Porter, C. J. H. (2011) · Molecular Pharmaceutics · doi:10.1021/mp1001872 · Cited by 64
Doxorubicin-formaldehyde conjugates targeting αvβ3 integrin
Burkhart, D. J., Kalet, B. T., Coleman, M. P., Post, G. C., & Koch, T. H. (2004) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.1593.3.12 · Cited by 64
Star-shaped immunoglobulin-containing HPMA-based conjugates with doxorubicin for cancer therapy
Etrych, T., Mrkvan, T., Říhová, B., & Ulbrich, K. (2007) · Journal of Controlled Release · doi:10.1016/j.jconrel.2007.06.007 · Cited by 63
Artificial polymeric cells for targeted drug delivery
Eniola‐Adefeso, O., & Hammer, D. A. (2003) · Journal of Controlled Release · doi:10.1016/s0168-3659(02)00346-2 · Cited by 62
Acid hydrolases in early and late endosome fractions from rat liver.
Runquist, E. A., & Havel, R. J. (1991) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)54608-1 · Cited by 61
Membrane‐type 1 MMP (MMP‐14) cleaves at three sites in the aggrecan interglobular domain
Fosang, A., Last, K., Fujii, Y., Seiki, M., & Okada, Y. (1998) · FEBS Letters · doi:10.1016/s0014-5793(98)00667-x · Cited by 61
Yura, H., Yoshimura, N., HAMASHIMA, T., Akamatsu, K., Nishikawa, M., Takakura, Y., & Hashida, M. (1999) · Journal of Controlled Release · doi:10.1016/s0168-3659(98)00150-3 · Cited by 61
Hervio, L., Coombs, G. S., Bergstrom, R. C., Trivedi, K. K., Corey, D. R., & Madison, E. L. (2000) · Chemistry & Biology · doi:10.1016/s1074-5521(00)00125-3 · Cited by 60
Tak, R. V., Pal, D., Gao, H., Dey, S., & Mitra, A. K. (2001) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.1101 · Cited by 60
Linear polyethyleneimine-based charge-reversal nanoparticles for nuclear-targeted drug delivery
Zhou, Z., Shen, Y., Tang, J., Jin, E., Ma, X., Sun, Q., Zhang, B., Kirk, E. A. V., & Murdoch, W. J. (2011) · Journal of Materials Chemistry · doi:10.1039/c1jm13576g · Cited by 59
Zhang, Y., Thomas, T. P., Desai, A. M., Zong, H., Leroueil, P. R., Majoros, I., & Baker, J. R. (2010) · Bioconjugate Chemistry · doi:10.1021/bc9003958 · Cited by 59
Zhang, A., Zhang, Z., Shi, F., Xiao, C., Ding, J., Zhuang, X., He, C., Chen, L., & Chen, X. (2013) · Macromolecular Bioscience · doi:10.1002/mabi.201300175 · Cited by 59
Chandran, S. S., Nan, A., Rosen, D. M., Ghandehari, H., & Denmeade, S. R. (2007) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-07-0392 · Cited by 59
Peroxisome matrix and membrane protein biogenesis
Ma, C., & Subramani, S. E. (2009) · IUBMB Life · doi:10.1002/iub.196 · Cited by 58
Research works printed but not linked: 47
- Majoros I. J., 2009, Wiley Interdiscip. Rev.: Nanomed. Nanobiotechnol., 1, 502
- Fischer M., 1999, Angew. Chem., Int. Ed., 38, 884, 10.1002/(sici)1521-3773(19990401)38:7<884::aid-anie884>3.0.co;2-k · DOI · Paper page
- Maeda H., 1989, Crit. Rev. Ther. Drug Carrier Syst., 6, 193
- Raha S., 2010, Wiley Interdiscip. Rev.: Nanomed. Nanobiotechnol., 3, 269
- Bhaskar V., 2003, Cancer Res., 63, 6387
- Hong S., 2007, Chem. Biol. (Oxford, U. K.), 14, 107
- Choi Y., 2005, Chem. Biol. (Oxford, U. K.), 12, 35
- Yellepeddi V. K., 2009, Anticancer Res., 29, 2933
- Maturo J., 1988, Biochem. Pharmacol. (Amsterdam, Neth.), 37, 3755
- de Groot F. M. H., 2002, Mol. Cancer Ther., 1, 901
- Bosnjakovic A., 2011, Nanomedicine (N. Y., NY, U. S.), 7, 284
- Levy G. A., 2006, Hepatology (Hoboken, NJ, U. S.), 43, 581
- Mahajan S. D., 2012, Methods in Enzymology, 509
- Salvi A., 1997, Drug Metab. Dispos., 25, 395
- Sanghani S. P., 2003, Clin. Cancer Res., 9, 4983
- Yoon K. J. P., 2003, Mol. Cancer Ther., 2, 1171
- Tougou K., 1998, Drug Metab. Dispos., 26, 355
- Barnes K. R., 2004, Chem. Biol. (Oxford, U. K.), 11, 557
- DeFeo-Jones D., 2000, Nat. Med. (N. Y., NY, U. S.), 6, 1248
- Wong B. K., 2001, Drug Metab. Dispos., 29, 313
- Hervio L. S., 2000, Chem. Biol. (Oxford, U. K.), 7, 443
- Silver D. A., 1997, Clin. Cancer Res., 3, 81
- Felsen C. N., 2014, Am. J. Physiol.: Lung Cell. Mol. Physiol., 306, L764
- Butler P. J., 1967, Biochem. J., 103, 78b
- Schmalfeldt B., 2001, Clin. Cancer Res., 7, 2396
- Incorvaia L., 2007, Anticancer Res., 27, 1519
- Trail P. A., 1992, Cancer Res., 52, 5693
- Hinman L. M., 1993, Cancer Res., 53, 3336
- Mahmud N. P., 1998, Anti-Cancer Drug Des., 13, 655
- Hunter F. W., 2012, Biochem. Pharmacol. (Amsterdam, Neth.), 83, 574
- van Haaften R. I. M., 2001, Biochem. Pharmacol. (Amsterdam, Neth.), 61, 715
- Rodrigues M. L., 1995, Cancer Res., 55, 63
- Rodrigues M. L., 1995, Chem. Biol. (Oxford, U. K.), 2, 223
- Goard M., 2005, Chem. Biol. (Oxford, U. K.), 12, 685
- Chourasia M. K., 2003, J. Pharm. Pharm. Sci., 6, 33
- Berchane N. S., 2007, Int. J. Pharm. (Amsterdam, Neth.), 337, 118
- Zhang M., 2011, Int. J. Nanomed., 6, 2337
- Kommareddy S., 2007, Nanomedicine (N. Y., NY, U. S.), 3, 32
- Mitran R.-A., 2014, Cent. Eur. J. Chem., 12, 1
- Wu C., 2011, Int. J. Pharm. (Amsterdam, Neth.), 403, 162
- Nelson J. L., 2002, Cancer Res., 62, 7280
- Li C., 1998, Cancer Res., 58, 2404
- Seymour L. W., 2002, J. Clin. Oncol., 20, 1668, 10.1200/jco.2002.20.6.1668 · doi:10.1200/jco.2002.20.6.1668 · Paper page
- Vasey P. A., 1999, Clin. Cancer Res., 5, 83
- Yokoyama M., 1991, Cancer Res., 51, 3229
- Wosikowski K., 2003, Clin. Cancer Res., 9, 1917
- Yurkovetskiy A., 2010, Cancer Res., 70
Cited by
Nano based drug delivery systems: recent developments and future prospects
Patra, J. K., Das, G., Fraceto, L. F., Campos, E. V. R., Rodriguez-Torres, M. D. P., Acosta-Torres, L. S., Diaz-Torres, L. A., Grillo, R., Swamy, M. K., Sharma, S., et al. (2018) · Journal of Nanobiotechnology · doi:10.1186/s12951-018-0392-8 · Cited by 6,684
Ghezzi, M., Pescina, S., Padula, C., Santi, P., Del Favero, E., Cantù, L., & Nicoli, S. (2021) · Journal of Controlled Release · doi:10.1016/j.jconrel.2021.02.031 · Cited by 1,135
Moradi Kashkooli, F., Soltani, M., & Souri, M. (2020) · Journal of Controlled Release · doi:10.1016/j.jconrel.2020.08.012 · Cited by 514
PAMAM dendrimers as efficient drug and gene delivery nanosystems for cancer therapy
Abedi-Gaballu, F., Dehghan, G., Ghaffari, M., Yekta, R., Abbaspour-Ravasjani, S., Baradaran, B., Ezzati Nazhad Dolatabadi, J., & Hamblin, M. R. (2018) · Applied Materials Today · doi:10.1016/j.apmt.2018.05.002 · Cited by 487
“However, the pH dependent cleavage of amide linkers including cis-aconityl, citraconyl and maleyl groups has been explored in controlled drug release [61].”
BackgroundTumor‐Microenvironment‐Responsive Nanomedicine for Enhanced Cancer Immunotherapy
Peng, S., Xiao, F., Chen, M., & Gao, H. (2022) · Advanced Science · doi:10.1002/advs.202103836 · Cited by 441
Metadata
- Authors
- Wong, P. T., & Choi, S. K.
- Affiliations
- University of Michigan (US)
- Corresponding author
- Choi, Seok Ki
- Venue
- Chemical Reviews
- Publisher
- American Chemical Society (ACS)
- Published
- 2015-04-27
- Volume
- 115
- Issue
- 9
- Pages
- 3388-3432
- ISSN
- 0009-2665 (ISSN-L)
- 1520-6890
- OpenAlex
- W2053890812
- Cited by
- 507
- References
- 493
- Citations by year
- 2026: 28 · 2025: 35 · 2024: 31 · 2023: 45 · 2022: 35 · 2021: 51 · 2020: 59 · 2019: 64 · 2018: 60 · 2017: 48 · 2016: 40 · 2015: 11
- FWCI
- 3.20
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Chemical Reviews (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Office of the Vice President for Research, University of Michigan
- Shanghai Jiao Tong University
- Topics
- Physical Sciences › Materials Science › Biomaterials › Nanoparticle-Based Drug Delivery
- Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Pharmaceutical Science › Advanced Drug Delivery Systems
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › RNA Interference and Gene Delivery
- Keywords
- drug release mechanism, nanomedicine, controlled drug release, anticancer agents, nanocarriers
- MeSH terms
- Theranostic Nanomedicine, Animals, Drug Carriers, Humans, Drug Liberation
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.